- Generic name
- Methyl Prednisolone
- Strength
- 4 mg
- Dosage form
- Tablet
- Manufactured by
- The ACME Laboratories Ltd.
Neolone 4 Tablet
About Neolone 4 Tablet
Neolone 4 is a tablet from The ACME Laboratories Ltd., with the generic name Methyl Prednisolone. Rheumatic uses include rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, bursitis, synovitis in osteoarthritis and tenosynovitis.
There are 22 brands of Methyl Prednisolone listed in Bangladesh. The lowest listed price is Depodrol 2 mg Tablet at ৳ 3 per unit.
What is Neolone 4 Tablet?
Neolone 4 comes as a tablet with 4 mg of Methyl Prednisolone, from The ACME Laboratories Ltd. Methyl Prednisolone belongs to a group of medicines called glucocorticoids, which are related to hormones the body makes naturally. It is a prescription medicine, so the dose, the length of the course and any changes should always be decided by your doctor. Whether it suits you is a decision for your doctor.
Uses of Neolone 4
Rheumatic uses include rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, bursitis, synovitis in osteoarthritis and tenosynovitis. Neolone 4 is used only for conditions a doctor has diagnosed. Your doctor will decide if it is suitable for you.
How to use Neolone 4
Take it with or without food as advised by your doctor. Neolone 4 is taken by mouth. Swallow the tablet with water. Take Neolone 4 4 mg tablet exactly as prescribed by your doctor. Always follow the instructions given by your doctor or pharmacist. Do not stop taking it suddenly without talking to your doctor, because your body may need time to adjust.
Side effects of Neolone 4
Short courses are often tolerated with few mild effects, but longer use or higher doses can cause more serious problems. Long-term use or high doses may cause more serious side effects. Reported effects include fluid retention, weight gain, high blood pressure, potassium loss, headache, muscle weakness and increased hair growth. Contact your doctor if you notice anything unusual after taking it. Ask your doctor or pharmacist about anything you are unsure of.
Safety and precautions
Its use in pregnancy and breastfeeding should be discussed with a doctor. Adrenocortical insufficiency can persist for months after stopping, so hormone therapy may need to be restarted during stress. Always consult your doctor before starting or stopping this medicine. Tell your doctor before starting if you are pregnant, planning pregnancy or breastfeeding, because Methyl Prednisolone is pregnancy category C and should be used only if the benefit justifies the risk to the foetus.
Frequently asked questions
What is Neolone 4 used for?
Rheumatic uses include rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, bursitis, synovitis in osteoarthritis and tenosynovitis. Neolone 4 is used only for conditions a doctor has diagnosed.
How do I use Neolone 4 correctly?
Take it with or without food as advised by your doctor. Neolone 4 is taken by mouth.
What should I watch for while using Neolone 4?
Short courses are often tolerated with few mild effects, but longer use or higher doses can cause more serious problems. Long-term use or high doses may cause more serious side effects.
Is Neolone 4 safe for everyone?
Its use in pregnancy and breastfeeding should be discussed with a doctor. Adrenocortical insufficiency can persist for months after stopping, so hormone therapy may need to be restarted during stress.
Indications
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing ... Read moreEndocrine Disorders: Primary or Secondary Adrenocortical Insufficiency, Congenital Adrenal Hyperplasia, Nonsuppurative Thyroiditis, Hypercalcemia associated with Cancer.
Rheumatic Disorders: Rheumatoid Arthritis. Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute and Subacute Bursitis, Synovitis of Osteoarthritis, Acute nonspecific Tenosynovitis, Post-traumatic Osteoarthritis, Psoriatic Arthritis, Epicondylitis, Acute Gouty Arthritis.
Collagen Diseases: Systemic lupus Erythematosus, Systemic Dermatomyositis and Acute Rheumatic Carditis.
Dermatologic Diseases: Bullous Dermatitis Herpetiformis, Severe Erythema Multiforme (Stevens-Johnson syndrome), Severe Seborrheic Dermatitis, Exfoliative Dermatitis, Mycosis Fungoides, Pemphigus, Severe Psoriasis.
Allergy: Seasonal or Perennial Allergic Rhinitis, Drug hypersensitivity reactions, Serum Sickness, Contact Dermatitis, Bronchial Asthma and Atopic Dermatitis;
Ophthalmic Diseases: Allergic Corneal Ulcers, Herpes Zoster Ophthalmicus, Anterior segment inflammation, Sympathetic Ophthalmia, Keratitis, Optic Neuritis, Allergic Conjunctivitis, Chorioretinitis, iritis end iridocyclitis.
Respiratory Diseases: Symptomatic sarcoidosis, Loeffler's syndrome not manageable by other means, berylliosis, Aspiration Pneumonitis.
Hematological Disorders: Idiopathic Thrombocytopenic Purpura in adults, Secondary Thrombocytopenia in adults, Acquired (Autoimmune) Hemolytic Anemia, Erythroblastopenia, Congenital (Erythroid) Hypoplastic Anemia.
Neoplastic Diseases: For palliative management of Leukemias and Lymphomas in adults, Acute leukemia of childhood.
Edematous States: To induce a diuresis or remission of Proteinuria in the Nephrotic Syndrome, without Uremia, of the idiopathic type or that due to Lupus Erythematosus.
Gastrointestinal Disease: To tide the patient over a critical period of the disease in Ulcerative Colitis & Regional Enteritis.
CNS Disease: Acute Exacerbations of Multiple Sclerosis.
Pharmacology
protein, and carbohydrate metabolism, skeletal muscle, the cardiovascular system, the immune system, the nervous system, and the endocrine system.
Pharmacokinetic properties: The absolute bioavailability of Methylprednisclone is generally high (82% to 89%) following oral administration and rapidly absorbed and the maximum plasma concentration is achieved around 1.5 to 2.3 hours across doses following oral administration in normal healthy adults. Methylprednisolone is widely distributed into the tissues and its volume of distribution is 41-61.5 liter. It crosses the Wood-brain barrier and the placental barrier and is secreted in breast milk. The plasma protein binding of Methylprednisolone in humans is approximately 77%. Methylprednisolone is metabolized in the liver to inactive metabolites. No dosing adjustments are necessary for renal failure. Methylprednisolone is haemodializable.
Dosage & Administration
As anti-inflammatory or immunosuppressive initial dosage: As anti-inflammatory or immunosuppressive, the initial dosage of Methylprednisolone tablets may vary from 4-48 mg per day depending on the specific disease entity being treated, in situations of less severity lower doses will generally suffice while in selected patients higher initial doses may be required. The initial dosage should be maintained or adjusted until a satisfactory response is noted. If after a reasonable period of time there is a lack of satisfactory dirtied response, Methylprednisolone should be discontinued and the patient transferred to other appropriate therapy. It should be emphasized that dosage requirements are variable and must be Individualized on the basis of the disease under treatment and the response of the patient.
As anti-inflammatory or immunosuppressive maintenance dosage: After a favorable response is noted, the proper maintenance dosage should be determined by decreasing the initial drug dosage in small decrements at appropriate time intervals until the lowest dosage which will maintain an adequate clinical response is reached. It should be kept in mind that constant monitoring is needed in regard to drug dosage. If after long-term therapy the drug is to be stopped, it is recommended that it be withdrawn gradually rather than abruptly.
Multiple Sclerosis: In the treatment of acute exacerbations of multiple sclerosis, daily doses of 160 mg of Methylprednisolone for a week followed by 64 mg every other day for 1 month have been shown to be effective.
Methylprednisolone 4 mg tablet can be used to treat and to control severe allergy end dermatitis following the guideline listed below to minimize the steroid withdrawal syndromes:
- Day 1: 2 tablets before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 2: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 2 tablets at bedtime
- Day 3: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet after dinner + 1 tablet at bedtime
- Day 4: 1 tablet before breakfast + 1 tablet after lunch + 1 tablet at bedtime
- Day 5: 1 tablet before breakfast + 1 tablet at bedtime
- Day 6: 1 tablet before breakfast
The following should be kept in mind when considering alternate-day therapy:
- Basic principles and indications for corticosteroid therapy should be applied.
- Alternate-day therapy is a therapeutic technique primarily designed for pefienis in whom long-term pharmacologic corticoid therapy is anticipated.
- In less severe disease processes in which corticoid therapy is indicated, it may be possible to initiate treatment with alternate-day therapy. More severe disease state usually will require daily divided high dose therapy for initiai control of the disease process. The initial suppressive dose level should be continued until a satisfactory clinical response is obtained, usually four to ten days in the case of many allergic and collagen diseases.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Precautions & Warnings
Overdose Effects
Storage Conditions
Alternative brands of Methyl Prednisolone
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.